Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth
and proliferation. These metabolic alterations include (1) a shift from oxidative …

Cancer is characterized by metabolic reprogramming, which is a hot topic in tumor treatment
research. Cancer cells alter metabolic pathways to promote their growth, and the common …

Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are
classified as non-small cell lung cancers (NSCLC). EGFR has become an important …

Objective Community-acquired pneumonia (CAP) is the primary cause of death for children
under five years of age globally. Hence, it is essential to investigate new early biomarkers …

Small cell lung cancer (SCLC) is one of the deadliest human cancers, with a 5-year survival
rate of∼ 7%. Here, we performed a targeted proteomics analysis of human SCLC samples …

Prostate cancer (PC) is the second most common tumor in males worldwide. The lack of
effective medication and the development of multidrug resistance towards current …

Non-small cell lung cancer (NSCLC) is a primary histological subtype of lung cancer with
increased morbidity and mortality. K+ channels have been revealed to be involved in …

Metabolism differs significantly between tumor and normal cells. Metabolic reprogramming
in cancer cells and metabolic interplay in the tumor microenvironment (TME) are important …

Ethnopharmacological relevance Codonopsis pilosula (C. pilosula), also called “Dangshen”
in Chinese, is derived from the roots of Codonopsis pilosula (Franch.) Nannf.(C. pilosula) …

Increased glutamine metabolism is a hallmark of many cancer types. In recent years, our
understanding of the distinct and diverse metabolic pathways through which glutamine can …